Loading the company…
Loading the company…
Families: Bronchoscopy & lung nodule, Colonoscopy & upper endoscopy, Kidney stone management, ERCP & endoscopic ultrasound, Skin substitutes & wound grafts.
All companies · Product and company coverage
In the last ten years FDA made 16 decisions for Ambu (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 5 procedure families, the most in 2024 (5). The latest was on 2026-09-16.
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-09-16 | 510(k) | K260309 | Ambu® aScope 5 Broncho 2.7/1.2; Ambu® aScope 5 Broncho 4.2/2.2; Ambu® aScope 5 Broncho 4.2/2.2 Sampler Set |
| 2026-09-16 | 510(k) | K261400 | Ambu® aScope Gastro; Ambu® aScope Gastro Large |
| 2024-08-16 | 510(k) | K242108 | Ambu® aScope 5 Uretero (Standard Deflection); Ambu® aScope 5 Uretero (Reverse Deflection); Ambu® aView 2 Advance |
| 2024-06-24 | 510(k) | K233630 | Ambu® aScope 5 Uretero (Standard Deflection); Ambu® aScope 5 Uretero (Reverse Deflection); Ambu® aBox 2 |
| 2024-04-16 | 510(k) | K233886 | Ambu® aScope Duodeno 2, Ambu® aBox 2 |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Ambu.